Doroteya Raykova

Doroteya Raykova's work experience includes roles at various organizations, primarily in the field of pharmaceutical cell biology and molecular tools.

From 2017 to 2022, they worked at Uppsala University as a Researcher in Pharmaceutical Cell Biology. Their responsibilities involved developing in situ analyses of cell signaling activity using both conventional and new methods for protein detection.

Prior to that, they served as a Postdoc in Molecular Tools at Uppsala University's Department of Immunology, Genetics, and Pathology from 2015 to 2016. During this time, they worked on establishing primary cell lines and reprogramming them to iPSCs. Doroteya also improved reprogramming efficiency through modifications of lentiviral vectors used for delivering reprogramming factors.

In 2011, Doroteya Raykova worked as a Project Student at Uppsala University's Department of Immunology, Genetics, and Pathology. Their role involved the establishment of primary cell lines and enhancing reprogramming efficiency using modified lentiviral vectors.

Most recently, they joined Navinci Diagnostics in 2022 as an Application Scientist. Specific details about their role at this company have not been provided.

Doroteya Raykova has a strong educational background in the field of genetics and molecular biology. Doroteya obtained their high school diploma from the First English Language School in 2005. Following this, they went on to pursue a Bachelor of Science (B.Sc.) in Molecular Biology from Sofia University St. Kliment Ohridski, which they completed in 2009. Doroteya then continued their education at Uppsala University, where they earned a Master's degree in Biomedical Science from 2009 to 2011. Doroteya further pursued their academic journey at Uppsala University, completing a Doctor of Philosophy (PhD) degree in Human/Clinical Genetics and Stem Cell Biology from 2012 to 2015.